Fiche société
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications1liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| eslicarbacepineKnowing the impact that the use of ESL as adjunctive treatment of partial epilepsy has on cardiovascular risk factors measured by biochemical and ultrasound parameters compared with enzyme-inducing AEDs. | Épilepsie | À vérifier | À vérifier | Spain | À vérifier |
| eslicarbacepineKnowing the impact that the use of ESL as adjunctive treatment of partial epilepsy has on cardiovascular risk factors measured by biochemical and ultrasound parameters compared with enzyme-inducing AEDs. | Épilepsie | À vérifier | À vérifier | Spain | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| eslicarbacepine | Épilepsie | À vérifier | NCT02573272 | Impact of Eslicarbazepine Acetate on Lipid Metabolism and Cardiovascular Risk Factors | UNKNOWN |
Publications
1| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| eslicarbacepine | Facial solitary morphea profunda presenting with painful trigeminal neuropathy: A case report. | Cephalalgia : an international journal of headache |